Plain-English translation of NCT07069452 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study, called TARGET-ASPECT, follows patients who have had an acute ischemic stroke and received both clot-busting medication and a procedure to physically remove the blood clot from their brain. Researchers want to understand whether specific brain imaging measurements โ especially when used together โ can better predict how well patients will recover 3 months after their stroke. Even with current treatments, about half of stroke patients don't fully recover, so finding better prediction tools could help doctors make smarter treatment decisions.
Right now, doctors have difficulty predicting which stroke patients will have good outcomes even after receiving the best available treatments. By identifying which brain imaging scores work best โ alone or combined โ doctors may be able to give patients more accurate information about their recovery prospects and make better decisions about their care.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will have already received standard stroke treatment (clot-busting medicine and clot removal procedure) as part of your regular care. Researchers will review your brain imaging scans taken during and after your treatment, and they will check in with you or your medical team at the 90-day mark to see how well you've recovered. The study lasts about 9 months total and involves 152 patients.
AI-generated summary from trial data ยท Aug 15, 2026 ยท Not medical advice
France
Sponsor
Centre Hospitalier de Gonesse
Enrollment target
~152 participants
Started
April 2025
Primary completion
January 2026
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.